165 related articles for article (PubMed ID: 16167236)
1. [Prognostic significance of survivin splicing variants in expression gastric cancer].
Meng H; Dai DJ; Lu CD
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):234-6. PubMed ID: 16167236
[TBL] [Abstract][Full Text] [Related]
2. Expression level of wild-type survivin in gastric cancer is an independent predictor of survival.
Meng H; Lu CD; Sun YL; Dai DJ; Lee SW; Tanigawa N
World J Gastroenterol; 2004 Nov; 10(22):3245-50. PubMed ID: 15484293
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
4. [Elevated expression level of wild-type survivin in gastric cancer promotes in vitro docetaxel-resistance].
Meng H; Lu CD; Dai DJ; Sun YL; Tanigawa N
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2060-3. PubMed ID: 15730616
[TBL] [Abstract][Full Text] [Related]
5. Expression of survivin and caspase-3 in gastric cancer.
Kania J; Konturek SJ; Marlicz K; Hahn EG; Konturek PC
Dig Dis Sci; 2003 Feb; 48(2):266-71. PubMed ID: 12643601
[TBL] [Abstract][Full Text] [Related]
6. Expression of survivin and its splice variants in gastric cancer.
Cheng Z; Hu L; Fu W; Zhang Q; Liao X
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):393-8. PubMed ID: 17828494
[TBL] [Abstract][Full Text] [Related]
7. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
He XF; Wen DG; Hou JQ; He J; Cen JN
Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional expression of survivin and its splice variants in cervical carcinomas.
Futakuchi H; Ueda M; Kanda K; Fujino K; Yamaguchi H; Noda S
Int J Gynecol Cancer; 2007; 17(5):1092-8. PubMed ID: 17877643
[TBL] [Abstract][Full Text] [Related]
9. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
10. Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer.
Ikeguchi M; Kaibara N
Int J Mol Med; 2001 Dec; 8(6):661-6. PubMed ID: 11712083
[TBL] [Abstract][Full Text] [Related]
11. Effect of survivin on cell proliferation and apoptosis in gastric cancer.
Wakana Y; Kasuya K; Katayanagi S; Tsuchida A; Aoki T; Koyanagi Y; Ishii H; Ebihara Y
Oncol Rep; 2002; 9(6):1213-8. PubMed ID: 12375022
[TBL] [Abstract][Full Text] [Related]
12. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
Wagner M; Schmelz K; Wuchter C; Ludwig WD; Dörken B; Tamm I
Int J Cancer; 2006 Sep; 119(6):1291-7. PubMed ID: 16619249
[TBL] [Abstract][Full Text] [Related]
13. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
Span PN; Tjan-Heijnen VC; Heuvel JJ; de Kok JB; Foekens JA; Sweep FC
Clin Chem; 2006 Sep; 52(9):1693-700. PubMed ID: 16873289
[TBL] [Abstract][Full Text] [Related]
14. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of apoptosis proteins in human cervical cancer.
Espinosa M; Cantú D; Herrera N; Lopez CM; De la Garza JG; Maldonado V; Melendez-Zajgla J
BMC Cancer; 2006 Feb; 6():45. PubMed ID: 16504151
[TBL] [Abstract][Full Text] [Related]
16. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia.
Tröger A; Siepermann M; Mahotka C; Wethkamp N; Bülle H; Laws HJ; Escherich G; Janka-Schaub G; Göbel U; Dilloo D
Klin Padiatr; 2007; 219(3):127-33. PubMed ID: 17525905
[TBL] [Abstract][Full Text] [Related]
17. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer.
Miyachi K; Sasaki K; Onodera S; Taguchi T; Nagamachi M; Kaneko H; Sunagawa M
Gastric Cancer; 2003; 6(4):217-24. PubMed ID: 14716515
[TBL] [Abstract][Full Text] [Related]
18. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
19. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736
[TBL] [Abstract][Full Text] [Related]
20. Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients.
Nakamura M; Tsuji N; Asanuma K; Kobayashi D; Yagihashi A; Hirata K; Torigoe T; Sato N; Watanabe N
Cancer Sci; 2004 Jan; 95(1):44-51. PubMed ID: 14720326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
